Correlation Between Milestone Pharmaceuticals and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Foghorn Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Foghorn Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and Foghorn Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Milestone and Foghorn is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Foghorn Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the Foghorn Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Milestone Pharmaceuticals is 1.66 times less risky than Foghorn Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Foghorn Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 449.00 in Foghorn Therapeutics on August 27, 2024 and sell it today you would earn a total of 335.00 from holding Foghorn Therapeutics or generate 74.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Foghorn Therapeutics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Foghorn Therapeutics |
Milestone Pharmaceuticals and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Foghorn Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.The idea behind Milestone Pharmaceuticals and Foghorn Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Foghorn Therapeutics vs. Eliem Therapeutics | Foghorn Therapeutics vs. HCW Biologics | Foghorn Therapeutics vs. Scpharmaceuticals | Foghorn Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |